Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q4 2023 ▲▼ | Q1 2024 ▲▼ | Change ▲▼ | Q4 2023 ▲▼ | Q1 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| ELEVATION ONCOLOGY INC | 2,914,255 | 2,696,133 | -218,122 | 1,565 | 13,831 | 4.91% | +12,266 |
| HARMONY BIOSCIENCES HLDGS IN(HRMY) | 1,035,396 | 1,035,396 | 0 | 33,443 | 34,769 | 12.33% | +1,325 |
| IMPEL PHARMACEUTICALS INC | 2,759,791 | 0 | -2,759,791 | 341 | 0 | — | -341 |
| ACELYRIN INC | 3,852,470 | 3,852,470 | 0 | 28,739 | 26,004 | 9.23% | -2,735 |
| ALX ONCOLOGY HLDGS INC(ALXO) | 9,699,925 | 9,699,925 | 0 | 144,432 | 108,154 | 38.37% | -36,278 |
| PHARVARIS N V COM | 4,919,504 | 4,289,304 | -630,200 | 137,992 | 99,126 | 35.17% | -38,866 |
| RAYZEBIO INC | 5,158,162 | 0 | -5,158,162 | 320,683 | 0 | — | -320,683 |